La vendita allo scoperto per Philip Morris Intl dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Philip Morris Intl. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Philip Morris Intl (NYSE:PM) Azioni, Report sulle vendite allo scoperto

PHILIP MORRIS INTERNATIONAL

Philip Morris Intl

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.

2023-04-20,New,York,Usa,Ups,Truck.,Ups,Is,One,Of

Analyst Color

News

Markets

Media

Trading Ideas

WING

Le valutazioni di Wall Street su tre titoli sotto i riflettori: il mercato reagisce alle parole di Cramer.

Jim Cramer si sbilancia su tre titoli: ecco cosa ha detto e perché

Shibuya,,Tokyo,,Japan,-,March,5,2022:,Exterior,Of,The

Long Ideas

Tech

PLTR

UBER

VRSN

Le azioni dell&#39;S&amp;P 500 che stanno registrando le migliori performance dell&#39;anno. Quali sono le società in forte crescita?

I migliori performer dell&#39;S&amp;P 500: ecco le azioni che stanno volando alto

June,29,,2020,,Brazil.,In,This,Photo,Illustration,The,Philip

Dividends

Price Target

Analyst Ratings

Philip Morris, Molson Coors e Hershey sotto la lente. Valutazioni e target price su aziende difensive con rendimenti da dividendo elevati.

Dividendi anti-crisi: 3 titoli consigliati dai migliori analisti

Philip Morris International Inc Common Stock

Philip Morris International Inc

Plasmatech Inc

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - April

Innovator U.S. Equity Power Buffer ETF - March

PREMIER INVESTMENTS LTD by Premier Investments Ltd.

Premier Investments Ltd

Powell Max Limited - Class A Ordinary Shares

Powell Max Ltd

Innovator U.S. Equity Power Buffer ETF - May

Pharmala Biotech Holdings Inc

PROMOTORA AMBIENTAL SAB B by Promotora Ambiental SAB de CV

Promotora Ambiental SAB de CV

PEMBINA PPLNE PFD A SER 7 by Pembina Pipeline Corp.

Pembina Pipeline Corp

PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund

PMB AEROSPACE CORP by PMB Aerospace Corporation

PMB Aerospace Corp

PharmaCyte Biotech Inc

PELOTON MINERALS CORP by Peloton Minerals Corporation

Peloton Minerals Corp

PT MERDEKA COPPER GLD TBK by PT MERDEKA COPPER GOLD TBK

PT Merdeka Copper Gold Tbk

Prospector Metals Corp

PROSPECTOR METALS CORP by PROSPECTOR METALS CORP.

Pro Medicus Ltd

Psychemedics Corp.

PSYCHEMEDICS CORP NEW by Psychemedics Corp.

Psychemedics Corp

PRO MEDICUS LTD U/ADR by Pro Medicus, Ltd.

PT MITRA ADIPERKASA TBK by Pt Mitra Adiperkasa Tbk

PT Mitra Adiperkasa Tbk

PT MITRA ADIPERKASA S/ADR by Pt Mitra Adiperkasa Tbk

PACE MEDICAL INC by Pace Medical, Inc.

PLATEAU MINERAL DEV INC by Plateau Mineral Development, Inc.

Plateau Mineral Development Inc

Sonoran Desert Copper Corp

SONORAN DESERT COPPER CP by SONORAN DESERT COPPER CORP

PHARMA FOODS INTL CO by Pharma Foods International Co., Ltd.

Pharma Foods International Co Ltd

PM&E Inc

Primech Holdings Ltd

PREDICTMEDIX AI INC by PREDICTMEDIX AI INC.

Predictmedix AI Inc

PATRIOT BATTERY METALS by PATRIOT BATTERY METALS INC

Patriot Battery Metals Inc

PIMCO Municipal Income Fund

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - February

Priveterra Acquisition Corp II Ordinary Shares - Class A

Priveterra Acquisition Corp II

Priveterra Acquisition Corp II Units (1 Ord Class A & 1/2 War)

Priveterra Acquisition Corp II Warrants (02/12/2025)

Perth Mint Gold Token

Perpetual Energy Inc

PRIME MERIDIAN HLDG CO by Prime Meridian Holding Co.

Prime Meridian Holding Co

PERFECT MED HLTH U/ADR by PERFECT MED HEALTH MGMT LTD.

POLOMAR HEALTH SVCS INC by Polomar Health Services, Inc.

Polomar Health Services Inc

PLASMA INNOVATIVE INC by PLASMA INNOVATIVE INC.

Plasma Innovative Inc

PGIM ETF Trust PGIM Municipal Income Opportunities ETF

PMI GROUP INC NEW by PMI Group, Inc. (The)

PMI Group Inc

PT MULTI INDOCITRA ORD by PT Multi Indocitra Tbk

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - January

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - June

PT MERCK TBK by PT Merck TBK

Playmaker Capital Inc Ordinary Shares

PINKMONKEY.COM INC by PinkMonkey.com, Inc.

PinkMonkey.com Inc

Pimco Municipal Income Fund II Common Shares of Beneficial Interest

PIMCO Municipal Income Fund II

Putnam Managed Municipal Income Trust Common Stock

Putnam Managed Municipal Income Trust

PUMA AG RUDOLF DASSLER SP by Puma AG Rudolf Dassler Sport

Puma SE

PEMBINA PIPELINE CORP PFD by Pembina Pipeline Corp.

Pampa Metals Corp Ordinary Shares

PAMPA METALS CORP by Pampa Metals Corporation

Pampa Metals Corp

PREMIUM EXPL INC by Premium Exploration, Inc.

Premium Exploration Inc

BlackRock ETF Trust iShares Prime Money Market ETF

PREMIUM GROUP CO LTD by PREMIUM GROUP CO LTD.

Premium Group Co Ltd

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - March

PRECIOUS METALS & MNG TR by Precious Metals & Mining Trust

Precious Metals and Mining Trust

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - May

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences Inc

Perfect Moment Ltd

PERSEUS MINING LTD ORD by Perseus Mining Ltd

Perseus Mining Ltd

Putnam Municipal Opportunities Trust Common Stock

Putnam Municipal Opportunities Trust

Harbour Energy PLC

Prismo Metals Inc

Polychain Monsters

PRISMONE GROUP INC by PrismOne Group, Inc.

PREMIER PRODUCTS GROUP by Premier Products Group, Inc.

Premier Products Group Inc

PRIMARIS REIT SER A UNIT by PRIMARIS REAL ESTATE INV TRUST TR.

Primaris REIT

POP MART INTL UNSP/ADR by Pop Mart International Group Limited

Pop Mart International Group Ltd

PROTEOME SCIENCES PLC by Proteome Sciences PLC

Proteome Sciences PLC

PRIMAL SOLUTIONS INC by Primal Solutions, Inc.

Primal Solutions Inc

PennyMac Mortgage Investment Trust Common Shares of Beneficial Interest

PennyMac Mortgage Investment Trust

PACIFIC METALS CO LTD by Pacific Metals Co., Ltd.

Pacific Metals Co Ltd

Perimeter Acquisition Corp I Class A Ordinary Shares

Perimeter Acquisition Corp I

PRECIOUS MTLS BULLION TR by Precious Metals Bullion Trust

Perimeter Acquisition Corp I Warrants (13/05/2030)

CPI Card Group Inc

PennyMac Mortgage Investment Trust 8.50% Senior Notes due 2028

PennyMac Mortgage Investment Trust 9.00% Senior Notes due 2030

PLAYMATES TOYS LTD ORD by Playmates Toys Ltd.

Playmates Toys Ltd

PennyMac Mortgage Investment Trust 8.125% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 8.00% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 6.75% Series C Cumulative Redeemable Preferred Shares of Beneficial Interest

PMV CONSUMER ACQ CORP A by PMV Consumer Acquisition Corp.

PMV Consumer Acquisition Corp

PMV CONSUMER ACQ A NEW by PMV Consumer Acquisition Corp.

PMV Consumer Acquisition Corp Warrants (31/08/2027)

PMV Pharmaceuticals Inc

PIMCO Municipal Income Fund III Common Shares of Beneficial Interest

PIMCO Municipal Income Fund III

Momentum traders are enjoying their best stretch in over a decade, with the strategy's flagship fund outpacing the broader U.S. market by the widest margin since records began — and it's a selective basket of stocks, led by Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), doing <a href="https://www.benzinga.com/screener/top-momentum-stocks">all the heavy lifting.</a>
<h1 class="wp-block-heading">Momentum Strategy Crushes S&amp;P 500</h1>
The iShares MSCI USA Momentum Factor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTUM#NYSE">MTUM</a>) is up 11.4% year-to-date through June, versus a modest 2% gain for the S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>). 
That nine percentage point lead marks the largest six-month outperformance since MTUM's launch in 2013.
While the absolute performance is below the first half of 2024 — when the AI-fueled rally sent momentum stocks soaring 25% — the relative gap is now wider, as the broader market cooled following U.S. trade tensions and rate uncertainty.
MTUM targets large- and mid-cap U.S. stocks showing strong recent price momentum, adjusting exposure semi-annually to overweight leaders and cut laggards. 
The momentum style has clearly paid off in 2025.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="528" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20102014/image-312-1024x528.png" alt="" class="wp-image-956198" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20102014/image-312-1024x528.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20102014/image-312-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20102014/image-312-768x396.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20102014/image-312-1536x792.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20102014/image-312-2048x1056.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h1 class="wp-block-heading">Five Stocks Are Driving The Momentum Rally – And Weighting Is The Key</h1>
Five stocks are powering the momentum&#8217;s outperformance in 2025, thanks to both strong returns and significantly higher weightings than in the S&amp;P 500.
<ol class="wp-block-list">
<li>Palantir Technologies has surged 83.4% year-to-date and carries a 3.72% weight in MTUM ETF versus just 0.6% in the SPY.</li>
<li>Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) is up 38.7% with a 4.88% weight, more than quadruple its 1.03% allocation in the SPY. </li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) has climbed 53.1%, with a 3.25% momentum weight compared to just 0.56% in the broader SPY.</li>
<li>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), up 18%, holds a 5.2% position in MTUM versus 3% in the SPY. </li>
<li>GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), up 47.5%, has a 2.13% weight in the momentum ETF, far above its 0.3% SPY weighting. </li>
</ol>
Together, these five names account for roughly 6.6 percentage points — or over half — of the MTUM's year-to-date return.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Stock Name</th>
<th>YTD Return</th>
<th>MTUM Weight</th>
<th>SPY Weight</th>
<th>MTUM Contribution</th>
<th>SPY Contribution</th>
</tr>
</thead>
<tbody>
<tr>
<td>Palantir Technologies Inc.</td>
<td>+83.4%</td>
<td>3.72%</td>
<td>0.6%</td>
<td>+197 bps</td>
<td>+26 bps</td>
</tr>
<tr>
<td>Netflix Inc.</td>
<td>+38.7%</td>
<td>4.88%</td>
<td>1.03%</td>
<td>+158 bps</td>
<td>+29 bps</td>
</tr>
<tr>
<td>Philip Morris International</td>
<td>+53.1%</td>
<td>3.25%</td>
<td>0.56%</td>
<td>+131 bps</td>
<td>+20 bps</td>
</tr>
<tr>
<td>Meta Platforms Inc.</td>
<td>+18.0%</td>
<td>5.20%</td>
<td>3.0%</td>
<td>+92 bps</td>
<td>+47 bps</td>
</tr>
<tr>
<td>GE Vernova Inc.</td>
<td>+47.5%</td>
<td>2.13%</td>
<td>0.3%</td>
<td>+80 bps</td>
<td>+9 bps</td>
</tr>
<tr>
<td>Cumulative Contribution</td>
<td>—</td>
<td>—</td>
<td>—</td>
<td>+658 bps</td>
<td>+131 bps</td>
</tr>
</tbody>
</table>
</figure>
Read Now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/eurozone/25/06/46026714/this-rare-market-dynamic-preceded-the-dot-com-crash-its-back-in-2025">This Rare Market Dynamic Preceded The Dot-Com Crash — It&#8217;s Back In 2025</a> Photo: Shutterstock<a href="https://www.benzinga.com/markets/eurozone/25/06/46026714/this-rare-market-dynamic-preceded-the-dot-com-crash-its-back-in-2025"> </a></li>
</ul>

Equities

Large Cap

Sector ETFs

Specialty ETFs

ETFs

MTUM

NFLX

The Palantir Effect: Momentum Stocks Are Making A Killing Like Never Before

In September 2024, Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) launched a CBD lozenge in collaboration with Vectura Fertin Pharma (now Aspeya, Inc.), a pharmaceutical firm owned by Philip Morris International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>). The dissolvable product, branded Luo, debuted on Aurora&#8217;s medical platform in Canada.
To some observers, it looked like a stealth alignment between cannabis and Big Tobacco. But according to Aurora CEO Miguel Martin, the story is more nuanced.
"Our relationship really is with Vectura Fertin," said Martin, noting the company now goes by the name Aspeya. "It's a broader health and wellness company, and it's really not so much with PMI, even though they have their own connection."
Aurora's strategy, he says, is grounded in medical science, not brand crossovers.
"We have always had a very conservative, pharmaceutically minded approach," Martin told <a href="https://www.benzinga.com/cannabis">Benzinga</a>. "To be able to partner with someone with [Vectura's] history, and particularly the technology they were bringing to ingestible cannabinoids, was exciting for us."
The companies launched the Luo lozenge in Canada as a physician-authorized product for patients seeking controlled CBD delivery. Aurora handles distribution through its direct-to-patient ecommerce platform. Martin said the partnership has been well-received and could expand in the future.
"This is really about learning and understanding… how that kind of science-based, medical approach is received. And it's been very well received," he said. "Our patients have enjoyed them. Hopefully, there's opportunity for other brand extensions."
Also read: <a href="https://www.benzinga.com/general/biotech/25/05/45386052/worlds-largest-tobacco-company-is-investing-in-medical-cannabis-heres-what-to-know">World&#8217;s Largest Tobacco Company Is Investing In Medical Cannabis: Here&#8217;s What To Know</a>
When asked whether this represented a deeper alignment with legacy industries, Martin was clear:
"Right now, it's about partnering and working with thoughtful, science-based, medically oriented companies," he said.
Aurora has similar relationships with prescribers, wholesalers and pharmaceutical partners across markets like Germany, Australia and the UK.
<h3 class="wp-block-heading">A Pharma-First Cannabis Strategy</h3>
The Luo lozenge deal, combined with Aurora's global medical push and Canada-first manufacturing strategy, fits into a broader vision Martin has reinforced consistently: that cannabis should follow pharmaceutical norms—from delivery methods to regulatory rigor.
Also read: <a href="https://www.benzinga.com/general/health-care/25/02/43666635/zyn-changed-nicotine-forever-are-cannabis-pouches-the-next-big-thing">Zyn Changed Nicotine Forever &#8211; Are Cannabis Pouches The Next Big Thing?</a>
"We're experts in medical cannabis," he said. "That's where all of our profitability comes from. If a partnership helps us improve patient outcomes and deliver consistency, we're open to it."
For now, that means dissolvable CBD lozenges backed by pharma-grade R&amp;D. Whether future deals bring Aurora closer to companies like PMI remains to be seen. But Martin insists the priority is patients, not optics.
"If it wasn't additive or accretive to our financials, we wouldn't do it," he said. "We don't chase headlines—we build around what works."
Photo: Shutterstock

Exclusives

Interview

EXCLUSIVE: Aurora Cannabis CEO Responds To Big Tobacco Concerns — It's Not That Kind Of Partnership

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>JP Morgan raised Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) price target from $141 to $154. JP Morgan analyst Matthew Boss maintained an Overweight rating. Ross Stores shares closed at $133.47 on Thursday. <a href="https://www.benzinga.com/quote/ROST/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays increased the price target for Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) from $205 to $220. Barclays analyst Gaurav Jain maintained an Overweight rating. Philip Morris shares closed at $184.10 on Thursday. <a href="https://www.benzinga.com/quote/PM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies raised EOG Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>) price target from $144 to $148. Jefferies analyst Lloyd Byrne maintained a Buy rating. EOG Resources shares closed at $120.59 on Thursday. See how other analysts <a href="https://www.benzinga.com/quote/EOG/analyst-ratings">view this stock</a>.</li>
<li>Rosenblatt raised the price target for Extreme Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) from $18 to $20. Rosenblatt analyst Mike Genovese maintained a Buy rating. Extreme Networks shares closed at $16.70 on Thursday. <a href="https://www.benzinga.com/quote/EXTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo raised the price target for DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) from $67 to $80. Wells Fargo analyst Michael Turrin upgraded the stock from Underweight to Equal-Weight. DocuSign shares closed at $76.01 on Thursday. <a href="https://www.benzinga.com/quote/DOCU/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup cut The Sherwin-Williams Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) price target from $405 to $385. Citigroup analyst Patrick Cunningham downgraded the stock from Buy to Neutral. Sherwin-Williams shares settled at $356.20 on Thursday. <a href="https://www.benzinga.com/quote/SHW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies raised Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) price target from $165 to $210. Jefferies analyst Andy Barish upgraded the stock from Underperform to Hold. Darden shares closed at $217.81 on Thursday. <a href="https://www.benzinga.com/quote/DRI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer increased Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) price target from $121 to $142. Oppenheimer analyst Rayna Kumar maintained an Outperform rating. Shift4 Payments shares closed at $93.31 on Thursday.  <a href="https://www.benzinga.com/quote/FOUR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays boosted the price target for Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) from $202 to $221. Barclays analyst Raimo Lenschow maintained an Overweight rating. Oracle shares settled at $199.86 on Thursday. <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) price target from $13 to $14. JP Morgan analyst Reginald Smith maintained an Overweight rating. Riot Platforms shares closed at $10.21 on Thursday. <a href="https://www.benzinga.com/quote/RIOT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ORCL stock? Here&#8217;s what analysts think:

DOCU

EXTR

FOUR

ORCL

RIOT

ROST

Oracle To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Friday

Barclays analyst Gaurav Jain maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Overweight and raises the price target from $205 to $220.

Barclays Maintains Overweight on Philip Morris Intl, Raises Price Target to $220

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) is a &#8220;very, very good company and a very good stock.&#8221; However, he added, &#8220;I just can't get behind it because <a href="https://www.benzinga.com/quote/PM/analyst-ratings">of what they do.&#8221;</a>
Supporting his view, B of A Securities analyst Lisa Lewandowski, on June 4, maintained Philip Morris Intl with a Buy rating and raised the price target from $182 to $200.
&#8220;That's a rough one for me,&#8221; Cramer said when asked about Wingstop Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>). &#8220;I don't see what they have that I'd like to see.&#8221;
On the earnings front, the restaurant franchise, on April 30, reported first-quarter earnings per share of 99 cents, beating the street view of 90 cents. Quarterly sales of $171.1 million (+17.4% year over year) marginally beat the analyst consensus estimate of $170.92 million.
United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) is a &#8220;very tough stock to own," Cramer said. &#8220;I don't know if it goes up from here.&#8221;
UPS, on June 2, announced the appointment of John Morikis to the UPS board of directors.
Price Action:
<ul class="wp-block-list">
<li>Wingstop shares gained 0.4% to settle at $376.13 on Monday.</li>
<li>Philip Morris fell 0.6% to settle at $180.63 on Monday.</li>
<li>UPS shares rose 1.1% to close at $99.31.</li>
</ul>
Read Next: 
<ul class="wp-block-list">
<li>T<a href="https://www.benzinga.com/news/25/06/45835438/top-3-financial-stocks-that-may-collapse-in-june">op 3 Financial Stocks That May Collapse In June</a></li>
</ul>
Image: Shutterstock

Jim Cramer: UPS Is A 'Very Tough Stock To Own'

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) has outperformed the market over the past 5 years by 6.19% on an annualized basis producing an average annual return of 20.73%. Currently, Philip Morris Intl has a market capitalization of $281.15 billion. 
Buying $1000 In PM: If an investor had bought $1000 of PM stock 5 years ago, it would be worth $2,535.16 today based on a price of $180.63 for PM at the time of writing.
<h3>Philip Morris Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749500119_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Philip Morris Intl 5 Years Ago Would Be Worth This Much Today

Large global tobacco companies are investing in and partnering with cannabis companies with eyes set on future growth <a href="https://www.benzinga.com/cannabis">for the sector.</a>
Industry experts shared the reasons why the cannabis sector is attractive to tobacco companies during the<a href="https://www.benzinga.com/cannabis-conference"> </a><a href="https://www.benzinga.com/cannabis-conference">2025 Benzinga Cannabis Capital Conference</a> in Chicago.
Tobacco Sector Looks to Cannabis: Among the major global tobacco operators,&nbsp;British American Tobacco&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>)&nbsp;and Philip Morris International&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) may differ in their approaches to entering and growing in <a href="https://www.benzinga.com/news/financing/25/03/44144069/big-tobaccos-latest-868m-cannabis-investment-signals-growing-industry-influence">the cannabis sector.</a>
KBS Strategic Advisors Lead Advisor Nick Kenny said Philip Morris has taken a more pharmaceutical and medical approach to the cannabis market, while British American Tobacco has looked more to consumer packaged goods in the sector.
Organigram Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) has secured two investments from British Tobacco, something highlighted by CEO Beena Goldenberg during the Benzinga panel.
Goldenberg said British American Tobacco was looking for a product development collaboration and research on cannabinoids in a federally legalized jurisdiction. A follow-on investment will now see the two companies look to international expansion.
This includes both British American Tobacco and Organigram investing in German company Sanity Group.
"More investments to come," Goldenberg said.
Alliance Global Partners Managing Director of Equity Research Aaron Grey said that what the cannabis sector is seeing now, related to tobacco, is a lot more strategic investments through partnerships or capital infusions.
"Investments are meant for a very specific reason," Grey said.
FoxNRTH Founder Chris Murray added that there is still a risk of a reputation for big tobacco companies in some regions, as cannabis is heavily stigmatized in some markets. This could be the reason for slow and steady entry into the sector instead of diving right in.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/05/45351523/organigram-lights-up-q2-with-74-sales-surge-profitable-turn">Organigram Lights Up Q2 With 74% Sales Surge, Profitable Turn</a>
What's Next For Tobacco Sector: Grey said Philip Morris could be slower before going heavily into the cannabis sector, with legality issues and recreational use having more risk.
"They've been consistent in their medical angle," Grey said.
Grey said the company will likely be conservative and look to learn more about the product.
"They've always been a little more conservative on that front."
For British American Tobacco, the company is looking at non-combustibles for growth.
"Vapes, edibles, beverages, that's the space," Goldenberg said.
The Organigram CEO said British American Tobacco wants to stay away from combustibles and reduce its risk with new products.
"Most tobacco companies are really looking to the future."
Goldenberg said a recent consumer survey showed that 90% of cannabis consumers are using multiple formats, which means the consumer of tomorrow is likely significantly different from the consumer of today.
With the market currently around 70% flower and pre-rolls, growth of other formats will likely mean 50% for flower and pre-rolls and 50% for vapes, beverages, edibles and other formats in the future, Goldenberg predicted.
Murray said the real exercise for tobacco companies is to investigate and learn more about it. He said the challenge of scaling the business is that you have to be relatively close to the space.
Kenny said there has to be an appetite for risk from the tobacco industry to keep investing in the cannabis space.
"Tobacco has a lot to lose," Kenny said.
Kenny added there are shareholder agreements, banking and insurance that factor into investments in the cannabis space, and there are likely internal battles for opportunity versus risk at tobacco companies.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/06/45823235/this-week-in-cannabis-americas-crackdown-down-on-hemp-global-reform-industry-gathering-in-chicago">This Week In Cannabis: America&#8217;s Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago</a></li>
</ul>
Photo: Chris Murray, Aaron Grey, Beena Goldenberg, Nick Kenny, Deepak Anand at Benzinga Cannabis Capital Conference, June 9, 2025; photo by Wendy Davis

Cannabis

Events

Global

EXCLUSIVE: Tobacco Sector Looks To Cannabis For Growth: 'Investments Are Meant For A Very Specific Reason'

B of A Securities analyst Lisa Lewandowski maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy and raises the price target from $182 to $200.

B of A Securities Maintains Buy on Philip Morris Intl, Raises Price Target to $200

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) has outperformed the market over the past 5 years by 5.09% on an annualized basis producing an average annual return of 19.02%. Currently, Philip Morris Intl has a market capitalization of $274.10 billion. 
Buying $1000 In PM: If an investor had bought $1000 of PM stock 5 years ago, it would be worth $2,386.50 today based on a price of $176.10 for PM at the time of writing.
<h3>Philip Morris Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748528119_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

The <a href="https://www.benzinga.com/topic/s-p-500">S&amp;P 500's leaderboard</a> for 2024 features some surprising names and familiar heavyweights. At the top sits NRG Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>), scorching ahead with over 70% gain year-to-date, fueled by a rally in power demand and clean energy transitions. 
Hot on its heels is heavyweight Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), posting a strong 64% YTD surge, making it the only stock from Cathie Wood's ARK Invest universe to crack the S&amp;P 500's top-performing <a href="https://finviz.com/screener.ashx?v=141&amp;f=idx_sp500&amp;o=-perfytd">list</a>.
Other solid performers include Howmet Aerospace Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) (+49% YTD), Philip Morris International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) (+47%) and Uber Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) (+38%), showing strength across energy, industrials, consumer staples, and tech-driven services. Not to be overlooked, General Electric Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) and GE Vernova Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) both shine with gains near 37%, while CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) and VeriSign, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>) round out a diverse group climbing the ranks.
Read Also: <a href="https://www.benzinga.com/general/space/25/05/45584539/donald-trumps-175-billion-golden-dome-could-trigger-a-new-space-arms-race-expert-warns-its-opening-a-pandoras-box">Donald Trump&#8217;s $175 Billion Golden Dome Could Trigger A New Space Arms Race, Expert Warns: &#8216;&#8230;It&#8217;s Opening A Pandora&#8217;s Box&#8217;</a>
Amid this broad mix, Palantir stands out &#8211; not just for its impressive gains but because it's the lone representative from Cathie Wood's innovation-driven ARK funds that's making waves among America's blue-chip giants. After a spectacular 485% surge over the past year, Palantir stock has captured investor attention with its cutting-edge data analytics and government contracts.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0526"><img loading="lazy" decoding="async" width="631" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/26073639/Screenshot-2025-05-26-at-5.06.19-PM.png" alt="" class="wp-image-927473" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/26073639/Screenshot-2025-05-26-at-5.06.19-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/26073639/Screenshot-2025-05-26-at-5.06.19-PM-300x231.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0526">Chart created using Benzinga Pro</a>
Technically, Palantir stock remains bullish, trading above its 20-day, 50-day and 200-day moving averages, classic signs that momentum could continue. The MACD (moving average convergence/divergence) indicator and RSI (relative strength index) indicators also support a bullish signal, suggesting Palantir stock's rally isn't finished yet.
However, Wall Street analysts take a more cautious stance. Recent ratings from New Street Research, Goldman Sachs, and Deutsche Bank average to a price target near $118 &#8211; only marginally above the current $123 price &#8211; implying limited upside for Palantir stock.
For Cathie Wood's ARK funds, Palantir remains the rare success story in the S&amp;P 500 this year, proving that selective innovation still has a place amid the index's top performers.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45603240/trump-agrees-to-extend-50-tariffs-on-europe-until-july-9-it-was-my-privilege-to-do-so">Trump Agrees To Extend 50% Tariffs On Europe Until July 9: &#8216;It Was My Privilege To Do So&#8217;</a></li>
</ul>
Image: Shutterstock/Hiroshi-Mori-Stock

Comments

Philip Morris Intl

Vendite allo scoperto

Philip Morris Intl (NYSE:PM) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO